ArticleDrug design, development and therapy2019

Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.

Mei Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.